ConductScience.org, home

Paper36906359

Chitosan particle-emulsion complex adjuvants: The effect of particle distribution on the immune intensity and response type.

Wu N and 5 others. Carbohydr Polym, 2023. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Chitosan particle-emulsion complex adjuvants: The effect of particle distribution on the immune intensity and response type. Papers, record 36906359. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36906359

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chitosan particle-emulsion complex adjuvants: The effect of particle distribution on the immune intensity and response type.
PubMed
Journal
Carbohydr Polym
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.57
iCite
Revised in PubMed
2023-11-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu NNan
2Chen QQiuting
3Zou YYongjuan
4Miao CChunyu
5Ma GGuanghui
6Wu JJie

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ChitosanMajor topic
VaccinesMajor topic
Adjuvants, Immunologic
Emulsions
Immunity, Cellular
Particle Size
Humans
Animals

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42713295Ultrasound-triggered chitosan interfacial crosslinking for core-shell nanoemulsions with enhanced salidroside bioaccessibility.Food Chem X2026https://conductscience.org/library/papers/42713295PubMed
41909730Tuning mechanical softness as a design principle in drug delivery: A biomechanical perspective.Acta Pharm Sin B2026https://conductscience.org/library/papers/41909730PubMed
41488455Polymeric particle-based antigen delivery system: From immunological engineering to clinical translation.Int J Pharm X2025https://conductscience.org/library/papers/41488455PubMed
41235367Polyethyleneimine-modified Laminarin nanoparticles enhance antigen delivery to lymph nodes by inducing transient inflammatory responses at the injection site.Mater Today Bio2025https://conductscience.org/library/papers/41235367PubMed
40860135Chitosan activates NLRP3 inflammasome and cGAS-STING to suppress cancer progression through hexokinase 2 dissociation and mitochondrial dysfunction.Theranostics2025https://conductscience.org/library/papers/40860135PubMed
40331611[Research advances of liposomes and exosomes in drug delivery and biomarker screening].Se Pu2025https://conductscience.org/library/papers/40331611PubMed
38258045Lipid-Based Nanotechnology: Liposome.Pharmaceutics2023https://conductscience.org/library/papers/38258045PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36906359

GET https://conductscience.org/api/papers/v1/36906359/authors